Despite statements by the Chair of the Federal Trade Commission (FTC), Lina Khan, and the Secretary of Health and Human Services (HHS), Xavier Becerra, that they would formally scrutinize anti-competitive practices by pharmacy benefit managers (PBMs), both agencies have yet to do so.